Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111208218 | 11120821 | 8 | F | 20150508 | 20160817 | 20150519 | 20160822 | EXP | BR-ROCHE-1579475 | ROCHE | 56.00 | YR | F | Y | 48.00000 | KG | 20160822 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111208218 | 11120821 | 1 | PS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 4 SESSIONS OF RITUXIMAB.?LATEST RITUXIMAB INFUSION ON 29/MAY/2015. | U | H0772B04 | 103705 | 500 | MG | SOLUTION FOR INFUSION | |||||
| 111208218 | 11120821 | 2 | C | PACLITAXEL. | PACLITAXEL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111208218 | 11120821 | 1 | Immune thrombocytopenic purpura |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 111208218 | 11120821 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111208218 | 11120821 | Conjunctival haemorrhage | |
| 111208218 | 11120821 | Erythema | |
| 111208218 | 11120821 | Off label use | |
| 111208218 | 11120821 | Pruritus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 111208218 | 11120821 | 1 | 20150508 | 0 |